CCAP Q1 2026 Earnings Narrow EPS Miss Highlights Steady Portfolio Returns Molecular Partners Q4 2025 Earnings EPS Beat Drives Shares Higher Amid Clinical Progress City Holding Company CHCO Q1 2026 Earnings Narrow EPS Beat Supports Modest Stock Gain BKYI Q1 2026 Earnings EPS Surprise Beats Estimates by 75 TAYD Q1 2026 Earnings EPS Slightly Above Estimates Amid Strong Operational Performance